IBDEI0Z3 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,15840,1,3,0)
;;=3^Progressive Systemic Sclerosis
;;^UTILITY(U,$J,358.3,15840,1,4,0)
;;=4^M34.0
;;^UTILITY(U,$J,358.3,15840,2)
;;=^5011778
;;^UTILITY(U,$J,358.3,15841,0)
;;=M34.1^^61^765^92
;;^UTILITY(U,$J,358.3,15841,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15841,1,3,0)
;;=3^CR(E)ST Syndrome
;;^UTILITY(U,$J,358.3,15841,1,4,0)
;;=4^M34.1
;;^UTILITY(U,$J,358.3,15841,2)
;;=^5011779
;;^UTILITY(U,$J,358.3,15842,0)
;;=M34.2^^61^765^313
;;^UTILITY(U,$J,358.3,15842,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15842,1,3,0)
;;=3^Systemic Sclerosis Induced by Drug/Chemical
;;^UTILITY(U,$J,358.3,15842,1,4,0)
;;=4^M34.2
;;^UTILITY(U,$J,358.3,15842,2)
;;=^5011780
;;^UTILITY(U,$J,358.3,15843,0)
;;=M34.81^^61^765^315
;;^UTILITY(U,$J,358.3,15843,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15843,1,3,0)
;;=3^Systemic Sclerosis w/ Lung Involvement
;;^UTILITY(U,$J,358.3,15843,1,4,0)
;;=4^M34.81
;;^UTILITY(U,$J,358.3,15843,2)
;;=^5011781
;;^UTILITY(U,$J,358.3,15844,0)
;;=M34.82^^61^765^316
;;^UTILITY(U,$J,358.3,15844,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15844,1,3,0)
;;=3^Systemic Sclerosis w/ Myopathy
;;^UTILITY(U,$J,358.3,15844,1,4,0)
;;=4^M34.82
;;^UTILITY(U,$J,358.3,15844,2)
;;=^5011782
;;^UTILITY(U,$J,358.3,15845,0)
;;=M34.83^^61^765^317
;;^UTILITY(U,$J,358.3,15845,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15845,1,3,0)
;;=3^Systemic Sclerosis w/ Polyneuropathy
;;^UTILITY(U,$J,358.3,15845,1,4,0)
;;=4^M34.83
;;^UTILITY(U,$J,358.3,15845,2)
;;=^5011783
;;^UTILITY(U,$J,358.3,15846,0)
;;=M34.89^^61^765^314
;;^UTILITY(U,$J,358.3,15846,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15846,1,3,0)
;;=3^Systemic Sclerosis NEC
;;^UTILITY(U,$J,358.3,15846,1,4,0)
;;=4^M34.89
;;^UTILITY(U,$J,358.3,15846,2)
;;=^5011784
;;^UTILITY(U,$J,358.3,15847,0)
;;=M34.9^^61^765^318
;;^UTILITY(U,$J,358.3,15847,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15847,1,3,0)
;;=3^Systemic Sclerosis,Unspec
;;^UTILITY(U,$J,358.3,15847,1,4,0)
;;=4^M34.9
;;^UTILITY(U,$J,358.3,15847,2)
;;=^5011785
;;^UTILITY(U,$J,358.3,15848,0)
;;=R21.^^61^765^297
;;^UTILITY(U,$J,358.3,15848,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15848,1,3,0)
;;=3^Rash/Nonspecific Skin Eruption
;;^UTILITY(U,$J,358.3,15848,1,4,0)
;;=4^R21.
;;^UTILITY(U,$J,358.3,15848,2)
;;=^5019283
;;^UTILITY(U,$J,358.3,15849,0)
;;=R23.3^^61^765^309
;;^UTILITY(U,$J,358.3,15849,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15849,1,3,0)
;;=3^Spontaneous Ecchymoses
;;^UTILITY(U,$J,358.3,15849,1,4,0)
;;=4^R23.3
;;^UTILITY(U,$J,358.3,15849,2)
;;=^5019295
;;^UTILITY(U,$J,358.3,15850,0)
;;=L03.113^^61^765^114
;;^UTILITY(U,$J,358.3,15850,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15850,1,3,0)
;;=3^Cellulitis of Right Upper Limb
;;^UTILITY(U,$J,358.3,15850,1,4,0)
;;=4^L03.113
;;^UTILITY(U,$J,358.3,15850,2)
;;=^5009033
;;^UTILITY(U,$J,358.3,15851,0)
;;=L03.114^^61^765^107
;;^UTILITY(U,$J,358.3,15851,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15851,1,3,0)
;;=3^Cellulitis of Left Upper Limb
;;^UTILITY(U,$J,358.3,15851,1,4,0)
;;=4^L03.114
;;^UTILITY(U,$J,358.3,15851,2)
;;=^5009034
;;^UTILITY(U,$J,358.3,15852,0)
;;=L03.115^^61^765^111
;;^UTILITY(U,$J,358.3,15852,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15852,1,3,0)
;;=3^Cellulitis of Right Lower Limb
;;^UTILITY(U,$J,358.3,15852,1,4,0)
;;=4^L03.115
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Z3 3773 printed Sep 23, 2025@19:34:33 Page 2
IBDEI0Z3 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,15840,1,3,0)
+2 ;;=3^Progressive Systemic Sclerosis
+3 ;;^UTILITY(U,$J,358.3,15840,1,4,0)
+4 ;;=4^M34.0
+5 ;;^UTILITY(U,$J,358.3,15840,2)
+6 ;;=^5011778
+7 ;;^UTILITY(U,$J,358.3,15841,0)
+8 ;;=M34.1^^61^765^92
+9 ;;^UTILITY(U,$J,358.3,15841,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,15841,1,3,0)
+12 ;;=3^CR(E)ST Syndrome
+13 ;;^UTILITY(U,$J,358.3,15841,1,4,0)
+14 ;;=4^M34.1
+15 ;;^UTILITY(U,$J,358.3,15841,2)
+16 ;;=^5011779
+17 ;;^UTILITY(U,$J,358.3,15842,0)
+18 ;;=M34.2^^61^765^313
+19 ;;^UTILITY(U,$J,358.3,15842,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,15842,1,3,0)
+22 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
+23 ;;^UTILITY(U,$J,358.3,15842,1,4,0)
+24 ;;=4^M34.2
+25 ;;^UTILITY(U,$J,358.3,15842,2)
+26 ;;=^5011780
+27 ;;^UTILITY(U,$J,358.3,15843,0)
+28 ;;=M34.81^^61^765^315
+29 ;;^UTILITY(U,$J,358.3,15843,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,15843,1,3,0)
+32 ;;=3^Systemic Sclerosis w/ Lung Involvement
+33 ;;^UTILITY(U,$J,358.3,15843,1,4,0)
+34 ;;=4^M34.81
+35 ;;^UTILITY(U,$J,358.3,15843,2)
+36 ;;=^5011781
+37 ;;^UTILITY(U,$J,358.3,15844,0)
+38 ;;=M34.82^^61^765^316
+39 ;;^UTILITY(U,$J,358.3,15844,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,15844,1,3,0)
+42 ;;=3^Systemic Sclerosis w/ Myopathy
+43 ;;^UTILITY(U,$J,358.3,15844,1,4,0)
+44 ;;=4^M34.82
+45 ;;^UTILITY(U,$J,358.3,15844,2)
+46 ;;=^5011782
+47 ;;^UTILITY(U,$J,358.3,15845,0)
+48 ;;=M34.83^^61^765^317
+49 ;;^UTILITY(U,$J,358.3,15845,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,15845,1,3,0)
+52 ;;=3^Systemic Sclerosis w/ Polyneuropathy
+53 ;;^UTILITY(U,$J,358.3,15845,1,4,0)
+54 ;;=4^M34.83
+55 ;;^UTILITY(U,$J,358.3,15845,2)
+56 ;;=^5011783
+57 ;;^UTILITY(U,$J,358.3,15846,0)
+58 ;;=M34.89^^61^765^314
+59 ;;^UTILITY(U,$J,358.3,15846,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,15846,1,3,0)
+62 ;;=3^Systemic Sclerosis NEC
+63 ;;^UTILITY(U,$J,358.3,15846,1,4,0)
+64 ;;=4^M34.89
+65 ;;^UTILITY(U,$J,358.3,15846,2)
+66 ;;=^5011784
+67 ;;^UTILITY(U,$J,358.3,15847,0)
+68 ;;=M34.9^^61^765^318
+69 ;;^UTILITY(U,$J,358.3,15847,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,15847,1,3,0)
+72 ;;=3^Systemic Sclerosis,Unspec
+73 ;;^UTILITY(U,$J,358.3,15847,1,4,0)
+74 ;;=4^M34.9
+75 ;;^UTILITY(U,$J,358.3,15847,2)
+76 ;;=^5011785
+77 ;;^UTILITY(U,$J,358.3,15848,0)
+78 ;;=R21.^^61^765^297
+79 ;;^UTILITY(U,$J,358.3,15848,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,15848,1,3,0)
+82 ;;=3^Rash/Nonspecific Skin Eruption
+83 ;;^UTILITY(U,$J,358.3,15848,1,4,0)
+84 ;;=4^R21.
+85 ;;^UTILITY(U,$J,358.3,15848,2)
+86 ;;=^5019283
+87 ;;^UTILITY(U,$J,358.3,15849,0)
+88 ;;=R23.3^^61^765^309
+89 ;;^UTILITY(U,$J,358.3,15849,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,15849,1,3,0)
+92 ;;=3^Spontaneous Ecchymoses
+93 ;;^UTILITY(U,$J,358.3,15849,1,4,0)
+94 ;;=4^R23.3
+95 ;;^UTILITY(U,$J,358.3,15849,2)
+96 ;;=^5019295
+97 ;;^UTILITY(U,$J,358.3,15850,0)
+98 ;;=L03.113^^61^765^114
+99 ;;^UTILITY(U,$J,358.3,15850,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,15850,1,3,0)
+102 ;;=3^Cellulitis of Right Upper Limb
+103 ;;^UTILITY(U,$J,358.3,15850,1,4,0)
+104 ;;=4^L03.113
+105 ;;^UTILITY(U,$J,358.3,15850,2)
+106 ;;=^5009033
+107 ;;^UTILITY(U,$J,358.3,15851,0)
+108 ;;=L03.114^^61^765^107
+109 ;;^UTILITY(U,$J,358.3,15851,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,15851,1,3,0)
+112 ;;=3^Cellulitis of Left Upper Limb
+113 ;;^UTILITY(U,$J,358.3,15851,1,4,0)
+114 ;;=4^L03.114
+115 ;;^UTILITY(U,$J,358.3,15851,2)
+116 ;;=^5009034
+117 ;;^UTILITY(U,$J,358.3,15852,0)
+118 ;;=L03.115^^61^765^111
+119 ;;^UTILITY(U,$J,358.3,15852,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,15852,1,3,0)
+122 ;;=3^Cellulitis of Right Lower Limb
+123 ;;^UTILITY(U,$J,358.3,15852,1,4,0)
+124 ;;=4^L03.115
